financetom
Business
financetom
/
Business
/
Tycoon Deripaska says Western firms shouldn't be pressured to sell Russian assets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tycoon Deripaska says Western firms shouldn't be pressured to sell Russian assets
Mar 17, 2024 9:57 AM

MOSCOW (Reuters) - Russian billionaire Oleg Deripaska has said that Western investors should not be pressured to sell their Russian assets, a practice he said was dishonest, short-sighted and harmful to the Russian and global economies.

Since Russia invaded Ukraine in 2022, many Western companies have fled Russia and some of their holdings have been put under state management, with allies of President Vladimir Putin gaining day-to-day control.

Some Western investors who have remained in Russia say they have come under pressure to sell up, being offered bargain-basement prices and threatened with effective expropriation.

"Pushing foreign companies to sell their Russian assets is dishonest, short-sighted and extremely harmful to the economy - not only the global economy, but also to Russia's," Deripaska was quoted saying by the Russian edition of Forbes magazine, remarks confirmed as accurate by a spokesman for Deripaska.

"It is important that the few Western investors who still work in Russia remain owners of their enterprises and be able to survive these difficult times."

In the wartime economy of Russia, some businessmen have become billionaires by acquiring the prime assets of Western companies at extremely discounted prices.

Since the invasion of Ukraine, Deripaska himself has been sanctioned by Britain for his alleged ties to Putin. He has mounted a legal challenge against the sanctions which he says are based on false information and ride roughshod over the basic principles of law and justice.

Deripaska, who studied physics at Moscow University, branched out into metals trading as the Soviet Union crumbled, making a fortune by buying up stakes in aluminium factories. Forbes ranked his fortune this year at $2.8 billion.

He founded Basic Element, an industrial group with interests in mining, energy, property and agriculture, on the base of his Siberian Aluminium which had gained control over some of the jewels of the post-Soviet aluminium sector.

Deripaska in 2022 called for peace in Ukraine and casts the war as a tragedy for both the Russian and Ukrainian people.

Deripaska has also been subjected to sanctions by the United States, which in 2018 took measures against him and other influential Russians because it said they were profiting from a Russian state engaged in "malign activities" around the world.

The sanctions, an attempt to punish Moscow for alleged meddling in the 2016 U.S. election, were "groundless, ridiculous and absurd", Deripaska said at the time.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Knightscope Sells Two More K1 Blue Light Towers to University of Texas
Knightscope Sells Two More K1 Blue Light Towers to University of Texas
Jul 29, 2024
12:41 PM EDT, 07/29/2024 (MT Newswires) -- Knightscope ( KSCP ) said Monday it has sold two additional K1 Blue Light Towers to the University of Texas for its Tyler, Texas, satellite campus. The K1 Blue Light Towers operate continuously in all weather conditions, and its Blue light emergency phone systems report one's precise location reliably, according to the company...
Dr. Reddy's Rituximab Biosimilar Recommended for Launch by EMA Committee
Dr. Reddy's Rituximab Biosimilar Recommended for Launch by EMA Committee
Jul 29, 2024
12:37 PM EDT, 07/29/2024 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Monday that a committee of the European Medicines Agency recommended the approval of its proposed Rituximab biosimilar in European markets. EMA's Committee for Medicinal Products for Human Use adopted a positive opinion recommending the launch of Dr. Reddy's DRL_RI in Europe. The approval is subject to final sign...
Carrier Global Analyst Re-evaluates Position After Q2 Earnings Exceed Expectations
Carrier Global Analyst Re-evaluates Position After Q2 Earnings Exceed Expectations
Jul 29, 2024
Shares of Carrier Global Corp ( CARR ) were trading higher on Monday, following the company’s announcement of its second-quarter results on Thursday. The company delivered on earnings despite weaker-than-expected Viessmann results and plans to repurchase shares worth $1 billion in the back half of 2024, according to BofA Securities. The Carrier Global ( CARR ) Analyst: Andrew Obin upgraded the...
NLS Pharmaceutics Signs Binding Term Sheet for Merger With Kadimastem; Shares Rise
NLS Pharmaceutics Signs Binding Term Sheet for Merger With Kadimastem; Shares Rise
Jul 29, 2024
12:31 PM EDT, 07/29/2024 (MT Newswires) -- NLS Pharmaceutics ( NLSP ) and cell therapy company Kadimastem said Monday that they signed a binding term sheet for a merger transaction, with Kadimastem becoming a subsidiary of NLS after the deal. The proposed merger transaction will see NLS issuing shares to Kadimastem shareholders who will own 85% of NLS' outstanding share...
Copyright 2023-2026 - www.financetom.com All Rights Reserved